SHENZHEN WEIGUANG BIOLOGICAL PRODUCTS CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 32.8 CNY | -5.20% |
|
+9.22% | -6.63% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
SHENZHEN WEIGUANG BIOLOGICAL PRODUCTS Co., Ltd. is a China-based high-tech company principally engaged in the research and development, production and sales of biological products. The Companyâs primary products are blood products, including the human serum albumin, human immunoglobulin, intravenous human immunoglobulin, freeze-dried intravenous human immunoglobulin, hepatitis B human immunoglobulin, Rabies immunoglobulin, tetanus immunoglobulin, histamine human immunoglobulin, and human fibrinogen. The Company mainly operates its businesses in domestic market.
Sector
Pharmaceuticals
Calendar
2024-05-17
- Annual General Meeting
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
32.8
CNY
Average target price
36
CNY
Spread / Average Target
+9.76%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -6.63% | 1.03B | |
| -2.61% | 89.08B | |
| +3.55% | 40.9B | |
| -14.40% | 32.25B | |
| +55.89% | 25.14B | |
| -15.96% | 15.39B | |
| -15.50% | 11.91B | |
| -41.29% | 11.89B | |
| -11.75% | 11.64B | |
| +7.87% | 9.03B |
- Stock Market
- Equities
- 002880 Stock
- News Shenzhen Weiguang Biological Products Co., Ltd.
- Weiguang Biological Products Halts Trading on Potential Change in Control